Sage Journals: Discover world-class research

Abstract

Aims

The purpose of this review was to assess the relationship between premature ovarian insufficiency (POI), defined as natural menopause <40 years, and risk of ischaemic heart disease (IHD), stroke and overall cardiovascular disease (CVD).

Methods and results

We performed a systematic search in PubMed (1966–2012), EMBASE (1980–2012). Studies were included if they were prospective, follow-up>3 years, assessment of age menopause <40 years, and incident cases of fatal or nonfatal IHD, stroke, or overall CVD. Relative risks (RRs) and 95% confidence interval (CI) were pooled using a random-effect model. Overall, 10 observational studies were identified, comprising 190,588 women (follow-up 4–37 years) with 9440 events (2026 events for IHD (seven studies) and 6438 events for stroke (seven studies) and 976 for total CVD (two studies). POI was assessed by questionnaire and incident cases through certification and event registers. POI was related to an increased risk of developing or dying from IHD (hazard ratio (HR) 1.69, 95% CI 1.29–2.21, p = 0.0001) and total CVD (HR 1.61, 95% CI 1.22–2.12, p = 0.0007). No relation was found for stroke (HR 1.03, 0.88–1.19, p = 0.74). We found no evidence for heterogeneity.

Conclusion

POI is an independent though modest risk factor of IHD and overall CVD but not of stroke. Because of the limited impact of POI on CVD risk compared to classical cardiovascular risk factors, it is unlikely that POI will be implemented as modifier of cardiovascular risk classification.

Keywords

Premature ovarian insufficiency premature ovarian failure menopause stroke ischaemic heart disease cardiovascular disease meta-analysis

Get full access to this article

View all access options for this article.

References

Nichols

Townsend

Luengo-Fernandez

. European cardiovascular disease statistics 2012, Brussels: European Heart Network, 2012.

Maas

van der Schouw

Regitz-Zagrosek

. Red alert for women's heart: The urgent need for more research and knowledge on cardiovascular disease in women: Proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010. Eur Heart J 2011; 32: 1362–1368.

Tan

Gast

van der Schouw

. Gender differences in risk factors for coronary heart disease. Maturitas 2010; 65: 149–160.

Jacobsen

Heuch

Kvale

. Age at natural menopause and stroke mortality: Cohort study with 3561 stroke deaths during 37-year follow-up. Stroke 2004; 35: 1548–1551.

van der Schouw

van der Graaf

Steyerberg

. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996; 347: 714–718.

Atsma

Bartelink

Grobbee

. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: A meta-analysis. Menopause 2006; 13: 265–279.

Wellons

Ouyang

Schreiner

. Early menopause predicts future coronary heart disease and stroke: The multi-ethnic study of atherosclerosis. Menopause 2012; 19: 1081–1087.

Nelson

. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009; 360: 606–614.

Stroup

Berlin

Morton

. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008–2012.

10.

Downs

Black

. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377–384.

11.

Baba

Ishikawa

Amagi

. Premature menopause is associated with increased risk of cerebral infarction in Japanese women. Menopause 2010; 17: 506–510.

12.

Choi

Lee

Kim

. Natural menopause and risk of stroke in elderly women. J Korean Med Sci 2005; 20: 1053–1058.

13.

Gallagher

Davis

Ray

. Reproductive history and mortality from cardiovascular disease among women textile workers in Shanghai, China. Int J Epidemiol 2011; 40: 1510–1518.

14.

Grodstein

Hennekens

. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999; 159: 1061–1066.

15.

Higgins

Thompson

. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.

16.

Cooper

Sandler

. Age at natural menopause and mortality. Ann Epidemiol 1998; 8: 229–235.

17.

Hong

Kang

. Age at menopause and cause-specific mortality in South Korean women: Kangwha Cohort Study. Maturitas 2007; 56: 411–419.

18.

Jacobsen

Knutsen

Fraser

. Age at natural menopause and total mortality and mortality from ischemic heart disease: The Adventist Health Study. J Clin Epidemiol 1999; 52: 303–307.

19.

Lokkegaard

Jovanovic

Heitmann

. The association between early menopause and risk of ischaemic heart disease: Influence of hormone therapy. Maturitas 2006; 53: 226–233.

20.

De Vos

Devroey

Fauser

. Primary ovarian insufficiency. Lancet 2010; 376: 911–921.

21.

Jacobsen

Nilssen

Heuch

. Does age at natural menopause affect mortality from ischemic heart disease? J Clin Epidemiol 1997; 50: 475–479.

22.

Koopman

van Dis

Bots

Hart-en vaatziekten in Nederland. In: Koopman

van Dis

Visseren

(eds). Hart-en vaatziekten in Nederland, Den Haag: Hartstichting, 2012, pp. 7–31.

23.

Stuenkel

. Cardiovascular risk and early menopause: Cause or consequence? Menopause 2012; 19: 1067–1069.

24.

Kok

van Asselt

van der Schouw

. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 2006; 47: 1976–1983.

25.

Luborsky

Meyer

Sowers

. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003; 18: 199–206.

26.

Stochholm

Juul

Juel

. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 2006; 91: 3897–3902.

27.

Lakhal

Braham

Berguigua

. Cytogenetic analyses of premature ovarian failure using karyotyping and interphase fluorescence in situ hybridization (FISH) in a group of 1000 patients. Clin Genet 2010; 78: 181–185.

28.

Yusuf

Hawken

Ounpuu

. Investigators IS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364: 937–952.

29.

Lloyd-Jones

Hong

Labarthe

. American Heart Association Strategic Planning Task F, Statistics C. Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010; 121: 586–613.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.29 MB

0.25 MB

Cardiovascular disease risk in women with premature ovarian insufficiency: A systematic review and meta-analysis

Abstract

Aims

Methods and results

Conclusion

Keywords

Get full access to this article

References

Supplementary Material